Cambricon and 6 other STAR Market leaders disclose operating results: AI industry chain boom is turning into profit
Cambricon, Biwin Storage, Shengyi Electronics, Yuanjie Technology, Lianxun Instruments and 6 other STAR Market companies collectively disclosed their operating results, of which 5 come from the AI industry chain. Cambricon's revenue in the first three quarters of 2026 was 9.526 billion yuan, up 106.76% year on year, and net profit attributable to shareholders was 3.715 billion yuan, up 131.49% year on year; Yuanjie Technology expects third-quarter revenue to grow 264.56% to 292.60% year on year.
Body · AI translation
Cailianshe Financial News Agency
Open the APP
① From AI computing power chips, storage and high-speed interconnect, to innovative drugs and interventional medical devices, companies have demonstrated the resilience of the STAR Market's fundamentals through performance growth, order reserves, R&D investment and capacity building. ② Relevant companies continue to achieve key technological breakthroughs, pushing domestic substitution in key industrial chains to greater depth. Scientific and technological self-reliance is being transformed into verifiable industrial progress and operating results, injecting stability into market expectations.
Science and Technology Innovation Board Daily, October 26 — In response to market concerns over short-term fluctuations in the technology sector, several leading STAR Market companies have responded to market concerns through announcements.
Recently, seven companies — Cambricon, Biwin Storage, Shengyi Electronics, Yuanjie Technology, Lianxun Instruments, RemeGen and APT Medical — disclosed their recent production and operating conditions in a concentrated manner. From AI computing power chips, storage and high-speed interconnect, to innovative drugs and interventional medical devices, companies have demonstrated the resilience of the STAR Market's fundamentals through performance growth, order reserves, R&D investment and capacity building.
A Science and Technology Innovation Board Daily reporter noted that, more importantly, relevant companies continue to achieve key technological breakthroughs, pushing domestic substitution in key industrial chains to greater depth. Scientific and technological self-reliance is being transformed into verifiable industrial progress and operating results, injecting stability into market expectations.
Among the seven STAR Market companies that made the above statements, five come from different links in the artificial intelligence industrial chain.
As can be seen from the relevant announcements, the prosperity signals of the industrial chain are not confined to the expectation level: chip companies' revenue and profits are growing rapidly, orders at PCB, optical chip and testing equipment companies remain strong, the demand structure for storage products is accelerating its upgrade, and capacity building and next-generation product verification are also advancing in parallel. Industrial chain demand driven by computing power capital expenditure is gradually being transformed into the operating results of listed companies.
As a computing power chip company, Cambricon stated that demand in the artificial intelligence computing power market is currently continuing to be robust, which can support the company's steady business growth. In the first three quarters of 2026, the company achieved operating revenue of 9.526 billion yuan, a year-on-year increase of 106.76%; net profit attributable to the parent company was 3.715 billion yuan, a year-on-year increase of 131.49%, up 80.38% from the full year of 2025. At the same time, the company's R&D investment in the first three quarters was 1.225 billion yuan, a year-on-year increase of 45.35%.
A Science and Technology Innovation Board Daily reporter found through statistics that Cambricon's single-quarter net profit once again hit a new high since its listing.
In Cambricon's view, as large model technology continues to evolve, the market not only needs more efficient computing power hardware to reduce training and inference costs, but also needs more complete software platforms to improve chips' ease of use, scalability, compatibility and stability in complex scenarios. The company will continue to maintain high-intensity R&D investment in key directions such as chip platforms and software platforms for large models, and strengthen software-hardware collaborative optimization capabilities.
The growth in computing power demand is also driving the upgrade of the storage industry. Biwin Storage stated that since 2026, affected by factors such as the continued advancement of artificial intelligence computing power infrastructure construction and the growth in storage demand from global data centers and cloud service providers, prices of major storage products such as DRAM and NAND Flash have risen significantly, and industry prosperity has improved. The company is actively expanding application markets such as emerging AI edge devices, PC and enterprise-level storage, and smart vehicles, and continues to advance the dual-wheel-driven strategy of "storage + wafer-level advanced packaging and testing," advancing technology R&D and industrial application in areas such as advanced storage, storage-computing integrated packaging and high-speed optoelectronic interconnect.
The PCB link is also feeling the rise in demand. Shengyi Electronics stated that the company currently has sufficient orders, a stable supply chain and a relatively high capacity utilization rate. Thanks to the high-prosperity demand in downstream fields such as AI computing power and high-speed communications, the company expects net profit attributable to the parent company in the first three quarters of 2026 to be 1.8686 billion yuan to 1.9517 billion yuan, a year-on-year increase of 68% to 75%.
Shengyi Electronics believes that as AI servers and high-speed switches accelerate their upgrades, high-speed, high-layer PCBs have become key components for ensuring high-speed signal integrity and supporting the stable release of computing power. Orders for the company's data center-related products such as AI servers and 800G and 1.6T switches are growing steadily, and 1.6T optical module products have achieved breakthrough progress.
▍Capacity release in the optical communications field is accelerating, and technology R&D remains at a relatively high intensity
In the high-speed optical communications field, Yuanjie Technology and Lianxun Instruments disclosed their latest operating progress from the laser chip and testing instrument links, respectively.
Yuanjie Technology expects to achieve operating revenue of 650 million yuan to 700 million yuan in the third quarter of 2026, a year-on-year increase of 264.56% to 292.60%; it expects net profit attributable to the parent company of 403 million yuan to 453 million yuan, a year-on-year increase of 578.85% to 659.70%.
In terms of technology and capacity, Yuanjie Technology's multiple products for new packaging technologies such as CPO and NPO are steadily advancing in line with customer needs, and R&D investment in EML and CW products remains at a relatively high intensity. The civil engineering works, part of the cleanrooms and supporting facilities of the second phase of its optoelectronic communications semiconductor chip and device R&D and production base have been completed, the first batch of production equipment is expected to enter the plant soon, and the project is expected to begin forming capacity between the end of 2026 and early 2027.
Lianxun Instruments stated that demand from its downstream customers is strong and its order reserves on hand are relatively sufficient. Core testing instruments such as sampling oscilloscopes, bit error rate analyzers and clock recovery units for 800G and 1.6T high-speed optical module testing are the company's main products to be delivered in 2026. The company expects net profit attributable to the parent company in the first three quarters of 2026 to be 1.9 billion yuan to 2.1 billion yuan, a year-on-year increase of 1866.00% to 2072.95%.
For next-generation rates, Lianxun Instruments' new-generation sampling oscilloscopes and supporting clock recovery units can meet the eye diagram testing requirements for 2.4T and 3.2T, and the related self-developed sample-and-hold chip has successfully completed tape-out and is planned to be sent to leading industry users for sample validation.
▍Momentum for the development of innovative drugs and medical devices continues to be released
The vitality of technological innovation is also reflected in the fields of biomedicine and high-end medical devices.
RemeGen stated that the commercialization of its core products is progressing steadily and overall operating quality continues to improve. In the first half of 2026, the company achieved operating revenue of 5.853 billion yuan, a year-on-year increase of 433.11%; net profit attributable to the parent company was 4.662 billion yuan, turning from loss to profit year on year; net cash flow from operating activities was 4.214 billion yuan, further enhancing profit quality and operational resilience.
In terms of internationalization, RemeGen has facilitated the completion of global licensing for four core drugs—telitacicept, disitamab vedotin, RC28 and RC148—with cumulative total transaction value exceeding US$12.6 billion. The company stated that it will continue to focus on core therapeutic areas such as autoimmune diseases and oncology, and advance clinical research, commercialization and global cooperation.
Huitai Medical is optimistic about the long-term demand for minimally invasive interventional medical devices. The company stated that its current production and operations are in good condition, product market coverage has further improved, and R&D capabilities have continued to strengthen. From 2021 to 2025, the company's operating revenue grew from 829 million yuan to 2.584 billion yuan, with a compound annual growth rate of 32.88%; net profit attributable to the parent company grew from 208 million yuan to 821 million yuan, with a compound annual growth rate of 40.95%. In the first half of 2026, the company's operating revenue and net profit attributable to the parent company increased by 25.75% and 26.38% year on year, respectively; in the first three quarters, the growth rates of operating revenue and net profit increased compared with the first half of the year.
Looking ahead, Huitai Medical will continue to increase the coverage rate and hospital penetration rate of vascular interventional products, accelerate the market access of pulsed ablation consumables, and promote the accelerated international market layout of three-dimensional electrophysiology systems, pulsed electric field ablation solutions and peripheral products. The company will also continue to advance digital and intelligent upgrades and strengthen technological innovation and commercialization of achievements in fields such as electrophysiology and vascular intervention.
▍Conveying confidence through operating performance and shareholder returns
The Science and Technology Innovation Board Daily reporter also noted that, in addition to disclosing industry trends and business progress, the relevant companies also responded to investor concerns through dividends, buybacks and other methods.
Since the beginning of 2026, Biwin Storage has completed the 2025 annual and 2026 interim equity distributions, with cumulative cash dividends of approximately 300 million yuan; the company also completed a share buyback of approximately 250 million yuan on October 19, with all relevant shares used for cancellation and reduction of registered capital. Its controlling shareholder, actual controller and chairman Sun Chengsi recently proposed again to repurchase company shares for 200 million yuan to 250 million yuan and use them for cancellation.
Shengyi Electronics paid a total of 741 million yuan in cash dividends for the 2025 annual and interim periods, accounting for 50.29% of the year's net profit attributable to the parent company; since its listing in 2021, the company has paid cumulative cash dividends of 1.486 billion yuan. The company also recently launched a share buyback plan of 100 million yuan to 200 million yuan.
Since its listing, Huitai Medical has implemented four rounds of buybacks, with buyback amounts exceeding 600 million yuan; from 2020 to 2025, it implemented cash dividends for six consecutive years, with cumulative cash dividends of 653 million yuan.
Cailian Press statement: The content of this article is for reference only and does not constitute investment advice. Investors who act accordingly do so at their own risk.
Business cooperation
Popular unlocks
[Master ETFs] The industry's fundamentals have bottomed out and stabilized, performance in segmented fields is strong, and the pace of order implementation should be watched going forward; related sectors are expected to see continued catalysts
① The industry's fundamentals have bottomed out and stabilized, performance in segmented fields is strong, and the pace of order implementation should be watched going forward; related sectors are expected to see continued catalysts; ② Last week, stock ETFs saw large net subscriptions and redemptions, with net inflows exceeding 150 billion yuan; ③ Institutions: From the perspective of valuation and performance, these directions can be watched for oversold rebounds.
[Nine O'Clock Special] Several embodied intelligence teams point out that GPT-6Astra still cannot make movements precise enough; analysts are optimistic that data collection is key to breakthroughs in brains and data, and its scarcity and irreplaceability are further highlighted; Kimi K3.1 Pro is released, surpassing GPT-6 in multiple tests
① Several embodied intelligence teams point out that GPT-6Astra still cannot make movements precise enough; analysts are optimistic that data collection is key to breakthroughs in brains and data, and its scarcity and irreplaceability are further highlighted. This company has entered AI algorithms, data collection and scenario system integration; ② Surpassing GPT-6 in multiple tests! Kimi K3.1 Pro is released, and institutions say the continued leap in foundation model capabilities will drive a synchronous improvement in the efficiency of the self-evolution loop of physical AI robot models. This company has carried out in-depth cooperation with Moonshot AI at the model integration level; ③ CrowdStrike rose 8.25%, and the company's CEO said there will be a large number of intrusion incidents in the coming months due to PHP vulnerabilities.
Related reading
A thousand robots compete in real-world scenarios in Shanghai; embodied intelligence accelerates toward production lines | On the ground at 2026GDPS
Science and Technology Innovation Board Daily reporter Huang Xinyi 2026-10-24 22:44
① Shanghai released ten real-world tracks for the International Embodied Intelligence Skills Competition. The ten tracks closely follow the three major dimensions of industry, special operations and services, focusing on creating real scenarios such as energy inspection, quality inspection, supermarket retail, emergency rescue, cultural tourism guidance, and medical care and rehabilitation. ② More than 800 competing teams and a thousand humanoid robots appeared together, concentratedly demonstrating that embodied intelligence is accelerating from laboratory prototypes to real production and life scenarios.
Cambricon's revenue and profit hit new highs! Q3 net profit attributable to the parent company up 147.74%
Science and Technology Innovation Board Daily reporter Guo Hui 2026-10-23 19:37
① Cambricon's third-quarter operating revenue was 3.531 billion yuan, a year-on-year increase of 104.47%; net profit attributable to shareholders of the listed company was 1.404 billion yuan, a year-on-year increase of 147.74%; ② Cambricon stated that the performance growth was mainly due to the company's continued market expansion and active efforts to help implement artificial intelligence applications.
Tech stocks adjust; is the high-growth logic still there? Leading STAR Market companies speak out: full orders, upward prosperity
Science and Technology Innovation Board Daily reporter Zeng Le 2026-10-23 08:34
① Both Yuanjie Technology and Lianxun Instruments stated that the company's production and operations, order delivery and capacity construction are all operating normally. ② With the explosive demand for AI computing power and high-performance computing, GAA, 3D NAND and 3D DRAM are accelerating their adoption, etching process complexity and per-wafer equipment usage are rising simultaneously, and the global etching equipment market space continues to expand.